Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 20;9(3):e023673.
doi: 10.1136/bmjopen-2018-023673.

Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study

Affiliations

Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study

Hiroaki Ogata et al. BMJ Open. .

Abstract

Objectives: Chronic obstructive airway disease, which is characterised by airflow limitation, is a major burden on public health. Reductions in environmental pollution in the atmosphere and workplace and a decline in the prevalence of smoking over recent decades may have affected the prevalence of airflow limitation in Japan. The present epidemiological study aimed to evaluate trends in the prevalence of airflow limitation and in the influence of risk factors on airflow limitation in a Japanese community.

Design: Two serial cross-sectional surveys.

Setting: Data from the Hisayama Study, a population-based prospective study that has been longitudinally conducted since 1961.

Participants: A total of 1842 and 3033 residents aged ≥40 years with proper spirometric measurements participated in the 1967 and 2012 surveys, respectively.

Main outcome measures: Airflow limitation was defined as forced expiratory volume in 1 s/forced vital capacity <70% by spirometry. For each survey, the age-adjusted prevalence of airflow limitation was evaluated by sex. ORs and population attributable fractions of risk factors on the presence of airflow limitation were compared between surveys.

Results: The age-standardised prevalence of airflow limitation decreased from 1967 to 2012 in both sexes (from 26.3% to 16.1% in men and from 19.8% to 10.5% in women). Smoking was significantly associated with higher likelihood of airflow limitation in both surveys, although the magnitude of its influence was greater in 2012 than in 1967 (the multivariable-adjusted OR was 1.63 (95% CI 1.19 to 2.24) in 1967 and 2.26 (95% CI 1.72 to 2.99) in 2012; p=0.007 for heterogeneity). Accordingly, the population attributable fraction of smoking on airflow limitation was 33.5% in 2012, which was 1.5-fold higher than that in 1967 (21.1%).

Conclusions: The prevalence of airflow limitation was decreased over 45 years in Japan, but the influence of smoking on airflow limitation increased with time.

Keywords: chronic airways disease; epidemiology; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: HI reports grants from Astellas, AstraZeneca, Boehringer-Ingelheim, ChugaiPharm, GlaxoSmithKline, Pfizer, MerckSharp and Dohme, Novartis and Teijin-Pharma, personal fees from Astellas, AstraZeneca, Boehringer-Ingelheim, Chugai-Pharm, GlaxoSmithKline, Kyorin, MerckSharp and Dohme, MeijiSeikaPharma, Novartis, Otsuka, Pfizer, Taiho, outside the submitted work.

Figures

Figure 1
Figure 1
Trends in the age-adjusted prevalence of airflow limitation in 1967 and 2012 by sex. Vertical bars indicate 95% CIs. *P<0.001 versus 1967. Airflow limitation was defined as forced expiratory volume in 1 s/forced vital capacity <70% according to the Global Initiative for Chronic Obstructive Lung Disease criteria.
Figure 2
Figure 2
Trends in the prevalence of airflow limitation according to age groups in 1967 and 2012 by sex. *P<0.05, p<0.01 versus 1967, p for trend <0.01. Airflow limitation was defined as forced expiratory volume in 1 s/forced vital capacity <70% according to the Global Initiative for Chronic Obstructive Lung Disease criteria.
Figure 3
Figure 3
Trends in the age-adjusted prevalence of airflow limitation according to severity in 1967 and 2012 by sex. Airflow limitation was defined as forced expiratory volume in 1 s/forced vital capacity <70% according to the Global Initiative for Chronic Obstructive Lung Disease criteria.
Figure 4
Figure 4
Multivariate-adjusted ORs and PAFs of risk factors for airflow limitation in 1967 and 2012. Airflow limitation was defined as forced expiratory volume in 1 s/forced vital capacity <70%. Adjustments were made for sex, age, smoking habits, overweight*, underweight*, hypertension and living alone. Horizontal bars indicate 95% CIs. *For the analysis of overweight and underweight, the normal weight group was used as the reference group. PAF, population attributable fraction; RF, risk factor.

References

    1. Vestbo J, Hurd SS, Agustí AG, et al. . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347–65. 10.1164/rccm.201204-0596PP - DOI - PubMed
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442–30. 10.1371/journal.pmed.0030442 - DOI - PMC - PubMed
    1. Adeloye D, Chua S, Lee C, et al. . Global and regional estimates of COPD prevalence: Systematic review and meta–analysis. J Glob Health 2015;5:20415 10.7189/jogh.05.020415 - DOI - PMC - PubMed
    1. Doney B, Hnizdo E, Dillon CF, et al. . Prevalence of airflow obstruction in U.S. Adults Aged 40-79 Years: NHANES Data 1988-1994 and 2007-2010. COPD 2015;12:355–65. 10.3109/15412555.2014.948998 - DOI - PMC - PubMed
    1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765–73. 10.1016/S0140-6736(07)61380-4 - DOI - PubMed

Publication types

MeSH terms